Ticker name:SMMT Summit Therapeutics Inc.
Country: US-Sector: Healthcare, Industry: Biotechnology
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, for combating multidrug resistant infections primarily carbapenem-resistant Enterobacteriaceae infections; and DDS-04 series for the potential treatment of infections caused by the Enterobacteriaceae. The company was founded in 2003 and is based in Cambridge, Massachusetts.
- CEO: Robert W. Duggan
- IPO: Mar 05, 2015
- Website:...ummittxinc.com (open a new tab)
Market Cap 11B
Last close 14.77$
Key metrics
Largest 20 companies In Biotechnology
| # Position | Ticker | Company Name | Market Cap | Last Price | Action |
|---|---|---|---|---|---|
| 1 | VRTX | VERTEX PHARMACEUTICALS INC / MA | 113B | 446.83$ | |
| 2 | REGN | REGENERON PHARMACEUTICALS, INC. | 67B | 635.45$ | |
| 3 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | 40B | 303.05$ | |
| 4 | RPRX | Royalty Pharma plc | 32B | 55.87$ | |
| 5 | RVMD | Revolution Medicines, Inc. | 32B | 149.23$ | |
| 6 | UTHR | UNITED THERAPEUTICS Corp | 23B | 549.87$ | |
| 7 | ROIV | Roivant Sciences Ltd. | 21B | 28.58$ | |
| 8 | INCY | INCYTE CORP | 20B | 102.38$ | |
| 9 | INSM | INSMED Inc | 20B | 94.22$ | |
| 10 | MRNA | Moderna, Inc. | 19B | 47.44$ | |
| 11 | NBIX | NEUROCRINE BIOSCIENCES INC | 16B | 163.88$ | |
| 12 | GMAB | GENMAB A/S | 16B | 25.15$ | |
| 13 | JAZZ | Jazz Pharmaceuticals plc | 15B | 238.57$ | |
| 14 | EXEL | EXELIXIS, INC. | 13B | 52.7$ | |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13B | 67.61$ | |
| 16 | ASND | Ascendis Pharma A/S | 13B | 210.45$ | |
| 17 | IONS | IONIS PHARMACEUTICALS INC | 12B | 74.48$ | |
| 18 | AXSM | Axsome Therapeutics, Inc. | 12B | 232.32$ | |
| 19 | SMMT | Summit Therapeutics Inc. | 11B | 14.77$ | |
| 20 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | 11B | 486.98$ |